We are live on ! Find out more
LEGN icon

Legend Biotech
LEGN

150 hedge funds and large institutions have $2.87B invested in Legend Biotech in 2022 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 50 increasing their positions, 50 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

208% more call options, than puts

Call options by funds: $47.7M | Put options by funds: $15.5M

55% more capital invested

Capital invested by funds: $1.85B → $2.87B (+$1.02B)

45% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 22

40% more funds holding in top 10

Funds holding in top 10: 5 → 7 (+2)

6% more funds holding

Funds holding: 141 → 150 (+9)

0.39% more ownership

Funds ownership: 16.7% → 17.09% (+0.39%)

0% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 50

Holders
150
Holders Change
+9
Holders Change %
+6.38%
% of All Funds
2.53%
Holding in Top 10
7
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+40%
% of All Funds
0.12%
New
32
Increased
50
Reduced
50
Closed
22
Calls
$47.7M
Puts
$15.5M
Net Calls
+$32.2M
Net Calls Change
+$25.8M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$179M
2
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$32M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$24M
4
ITP
Iron Triangle Partners
Connecticut
+$20.9M
5
SC
Samlyn Capital
New York
+$19.2M

Top Sellers

1
HA
HHLR Advisors
Cayman Islands
-$106M
2
BBA
Baker Bros. Advisors
New York
-$48.7M
3
AllianceBernstein
AllianceBernstein
Tennessee
-$25.9M
4
PA
Perceptive Advisors
New York
-$22.4M
5
CII
Capital International Inc
California
-$22.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
51
Citadel Advisors
Florida
$6.64M +$1.86M +44,044 +57%
PHP
52
Parkman Healthcare Partners
Connecticut
$6.48M -$113K -2,666 -2%
CS
53
Credit Suisse
Switzerland
$6.38M -$840K -19,899 -15%
Citigroup
54
Citigroup
New York
$6.29M +$2.24M +53,094 +87%
Northern Trust
55
Northern Trust
Illinois
$5.68M +$372K +8,812 +9%
Canada Pension Plan Investment Board
56
Canada Pension Plan Investment Board
Ontario, Canada
$5.64M -$6.53M -154,710 -60%
Sumitomo Mitsui Trust Group
57
Sumitomo Mitsui Trust Group
Japan
$5.64M +$195K +4,613 +5%
EAM
58
EFG Asset Management
Oregon
$5.45M -$154K -3,636 -4%
N
59
Nuveen
North Carolina
$5.31M -$306K -7,249 -7%
TCM
60
TimesSquare Capital Management
New York
$5.03M +$232K +5,500 +6%
Janus Henderson Group
61
Janus Henderson Group
United Kingdom
$5.02M +$3.85M +91,099 New
UBS Group
62
UBS Group
Switzerland
$4.87M -$552K -13,065 -13%
Invesco
63
Invesco
Georgia
$4.7M +$1.1M +26,001 +44%
Vanguard Group
64
Vanguard Group
Pennsylvania
$4.59M +$241K +5,710 +7%
AAP
65
Ardsley Advisory Partners
Connecticut
$4.46M +$3.42M +81,000 New
CSS
66
Cubist Systematic Strategies
Connecticut
$4.38M +$1.16M +27,579 +53%
SSA
67
Schonfeld Strategic Advisors
New York
$4.28M +$372K +8,798 +13%
First Trust Advisors
68
First Trust Advisors
Illinois
$4.25M -$62.8K -1,486 -2%
New York State Common Retirement Fund
69
New York State Common Retirement Fund
New York
$3.57M +$2.74M +64,855 New
LP
70
LMR Partners
United Kingdom
$3.1M +$1.38M +32,749 +139%
Voloridge Investment Management
71
Voloridge Investment Management
Florida
$3.06M -$6.86M -162,342 -74%
HSBC Holdings
72
HSBC Holdings
United Kingdom
$2.99M +$299K +7,092 +15%
TCM
73
Tang Capital Management
California
$2.75M – – –
PAMS
74
Pictet Asset Management (Switzerland)
Switzerland
$2.61M -$86.9K -2,057 -4%
Bank of New York Mellon
75
Bank of New York Mellon
New York
$2.21M +$94.6K +2,240 +6%
1 2
3
4 5

LEGN Hedge Fund Activity: Q2 2022 in Review

150 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Legend Biotech (LEGN) for Q2 2022, worth a combined $2.87B — up 55% from $1.85B a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new LEGN positions and 22 closed out — a net gain of 10 holders — while 50 added to existing stakes and 50 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $179M. The largest seller was HHLR Advisors, cutting an estimated $106M.

  • 150 institutional investors held Legend Biotech (LEGN) as of Q2 2022, up from 141 in Q1 2022.
  • Funds reported $2.87B of Legend Biotech stock for Q2 2022, up 55% quarter-over-quarter.
  • 32 funds opened new Legend Biotech positions in Q2 2022 and 22 closed out, a net change of +10 holders.
  • The largest Legend Biotech buyer in Q2 2022 was Fidelity Investments, an estimated $179M added.
  • The largest Legend Biotech seller in Q2 2022 was HHLR Advisors, an estimated $106M sold.

Based on aggregated 13F filings for Q2 2022.